Anemia and associated factors among HIV/AIDS patients treated with antiretroviral therapy at Mizan-Tepi University Teaching Hospital, Southwest Ethiopia
Introduction Human immunodeficiency virus (HIV) and treatments given to HIV patients to reduce complications and fast disease progression, cause a series of hematological abnormalities. Anemia is among hematologic manifestations commonly observed in HIV-positive persons on treatments, initiated by m...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2024-09-01
|
| Series: | HIV & AIDS Review. International Journal of HIV-Related Problems |
| Subjects: | |
| Online Access: | https://hivaids.termedia.pl/Anemia-and-associated-factors-among-nHIV-AIDS-patients-treated-with-antiretroviral,151855,0,2.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Introduction
Human immunodeficiency virus (HIV) and treatments given to HIV patients to reduce complications and fast disease progression, cause a series of hematological abnormalities. Anemia is among hematologic manifestations commonly observed in HIV-positive persons on treatments, initiated by multiple factors. This study aimed to determine the prevalence of anemia and associated factors among patients on highly active antiretroviral therapy (HAART) at Mizan-Tepi University Teaching Hospital from June to September 2021.
Material and methods
A hospital-based cross-sectional study was conducted from June to September 2021 among HIV-positive patients on treatment at Mizan-Tepi University Teaching Hospital. Participants were selected with a convenient sampling technique, and pre-tested structured questionnaires were used for gathering important both socio-demographic and clinical data. Blood samples were collected for hemoglobin determination and CD4+ cell count. Data were entered using Epi-data manager and analyzed using a statistical package for social sciences.
Results
A total of 159 HIV/AIDS patients were included in the study. The overall prevalence of anemia was observed in 51 (32.1%) patients, out of which 20 (12.6% %) were males and 31 (19.5%) were females. Moreover, female subjects (AOR = 7.379; 95% CI: 2.369-22.985%), patients on HAART for ≤ 6 months (AOR = 6.065; 95% CI: 2.425-15.170%), and those with body mass index of < 18.5 kg/m2 (AOR = 5.283; 95% CI: 1.312-21.267%) were factors showing statistically significant association with anemia.
Conclusions
A high prevalence of anemia was observed among patients on antiretroviral treatment. Routine screening and strict follow-up of patients on treatment are needed. |
|---|---|
| ISSN: | 1730-1270 1732-2707 |